Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement.
暂无分享，去创建一个
F. van Leth | S. Niemann | K. Dheda | A. Mandalakas | M. Grobusch | N. Veziris | S. Gagneux | C. Horsburgh | M. Farhat | M. Merker | A. Whitelaw | M. Boeree | C. Lienhardt | E. Cambau | B. Molina-Moya | J. Domínguez | M. Gröschel | Florence Morel | P. Miotto | V. Cox | I. Kontsevaya | L. Guglielmetti | F. Conradie | F. Maurer | C. Lange | D. Chesov | Berit Lange | A. Dudnyk